- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
Iris Biotechnologies Inc
+ Add to WatchlistIRSB:US
0.3800 USD 0.00000.00%As of 20:10:00 ET on 05/14/2013.
Snapshot for Iris Biotechnologies Inc (IRSB)
| Open: | - | Day's Range: | - | Volume: | 300 |
|---|---|---|---|---|---|
| Previous Close: | 0.3800 | 52wk Range: | 0.2500 - 0.8000 | 1-Yr Rtn: | - |
Key Statistics for IRSB
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0420 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 5.01 |
| Shares Outstanding (M) | 13.19 |
| 30 Day Average Volume | 60 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IRSB
Company Profile & Key Executives for IRSB
Iris Biotechnologies, Inc. researches and develops a breast cancer diagnostic kit. The Company develops a nano-biochip gene expression kit and an artificial intelligence system that assist doctors in diagnosing breast cancer and then designing a treatment plan specific to the patient.
| Simon S M ChinChairman/President/CEO/CFO | Ronald Mark GemberlingChief Medical Officer |
| James LeblancVP:Operations | Ralph M SinibaldiVP:Product Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IRSB News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page